| Sample ID |
L-leucineRT (min) |
C1 RT (min) |
C1a RT (min) |
C2a RT (min) |
C2 RT (min) |
| NanoGENTTM Sample |
2.0 |
3 |
9 |
12 |
14 |
| NanoGENT Placebo |
2.0 |
|
|
|
|
| USP Standard (avg. of injs. #1 - 6) |
2.0 |
3 |
9 |
12 |
14 |
| % RPD (NanoGENTTM Sample inj #1 vs. # 2 of sample) |
0.0 |
0.1 |
0.2 |
0.3 |
0.0 |
| % RPD (Placebo inj #1 vs. # 2 of sample) |
0.0 |
|
|
|
|
| % RPD (NanoGENTTM Sample vs. USP Standard |
0.1 |
0.1 |
0.1 |
0.2 |
0.2 |
| %RPD (Placebo vs. USP Standard) |
0.0 |
|
|
|
|
| % RPD: percent relative difference |
% RPD: percent relative difference